These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 30111341)
1. Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials. Wirz Y; Meier MA; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Schroeder S; Nobre V; Annane D; Reinhart K; Damas P; Nijsten M; Shajiei A; deLange DW; Deliberato RO; Oliveira CF; Shehabi Y; van Oers JAH; Beishuizen A; Girbes ARJ; de Jong E; Mueller B; Schuetz P Crit Care; 2018 Aug; 22(1):191. PubMed ID: 30111341 [TBL] [Abstract][Full Text] [Related]
2. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis. Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612 [TBL] [Abstract][Full Text] [Related]
3. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Schuetz P; Wirz Y; Sager R; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bucher HC; Bhatnagar N; Annane D; Reinhart K; Branche A; Damas P; Nijsten M; de Lange DW; Deliberato RO; Lima SS; Maravić-Stojković V; Verduri A; Cao B; Shehabi Y; Beishuizen A; Jensen JS; Corti C; Van Oers JA; Falsey AR; de Jong E; Oliveira CF; Beghe B; Briel M; Mueller B Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007498. PubMed ID: 29025194 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523 [TBL] [Abstract][Full Text] [Related]
5. Effect of Antibiotic Discontinuation Strategies on Mortality and Infectious Complications in Critically Ill Septic Patients: A Meta-Analysis and Trial Sequential Analysis. Arulkumaran N; Khpal M; Tam K; Baheerathan A; Corredor C; Singer M Crit Care Med; 2020 May; 48(5):757-764. PubMed ID: 32191414 [TBL] [Abstract][Full Text] [Related]
6. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis. Prkno A; Wacker C; Brunkhorst FM; Schlattmann P Crit Care; 2013 Dec; 17(6):R291. PubMed ID: 24330744 [TBL] [Abstract][Full Text] [Related]
7. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944 [TBL] [Abstract][Full Text] [Related]
8. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Schuetz P; Wirz Y; Sager R; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bucher HC; Annane D; Reinhart K; Falsey AR; Branche A; Damas P; Nijsten M; de Lange DW; Deliberato RO; Oliveira CF; Maravić-Stojković V; Verduri A; Beghé B; Cao B; Shehabi Y; Jensen JS; Corti C; van Oers JAH; Beishuizen A; Girbes ARJ; de Jong E; Briel M; Mueller B Lancet Infect Dis; 2018 Jan; 18(1):95-107. PubMed ID: 29037960 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands. Kip MMA; van Oers JA; Shajiei A; Beishuizen A; Berghuis AMS; Girbes AR; de Jong E; de Lange DW; Nijsten MWN; IJzerman MJ; Koffijberg H; Kusters R Crit Care; 2018 Nov; 22(1):293. PubMed ID: 30424796 [TBL] [Abstract][Full Text] [Related]
10. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007498. PubMed ID: 22972110 [TBL] [Abstract][Full Text] [Related]
11. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Kopterides P; Siempos II; Tsangaris I; Tsantes A; Armaganidis A Crit Care Med; 2010 Nov; 38(11):2229-41. PubMed ID: 20729729 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission. Gonzalez Del Castillo J; Wilson DC; Clemente-Callejo C; Román F; Bardés-Robles I; Jiménez I; Orviz E; Dastis-Arias M; Espinosa B; Tornero-Romero F; Giol-Amich J; González V; Llopis-Roca F; Crit Care; 2019 Oct; 23(1):335. PubMed ID: 31665092 [TBL] [Abstract][Full Text] [Related]
13. Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial. Jeon K; Suh JK; Jang EJ; Cho S; Ryu HG; Na S; Hong SB; Lee HJ; Kim JY; Lee SM J Korean Med Sci; 2019 Apr; 34(14):e110. PubMed ID: 30977312 [TBL] [Abstract][Full Text] [Related]
14. Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: a patient-level meta-analysis from randomized controlled trials. Heilmann E; Gregoriano C; Wirz Y; Luyt CE; Wolff M; Chastre J; Tubach F; Christ-Crain M; Bouadma L; Annane D; Damas P; Kristoffersen KB; Oliveira CF; Stolz D; Tamm M; de Jong E; Reinhart K; Shehabi Y; Verduri A; Nobre V; Nijsten M; deLange DW; van Oers JAH; Beishuizen A; Girbes ARJ; Mueller B; Schuetz P Clin Chem Lab Med; 2020 Sep; 59(2):441-453. PubMed ID: 32986609 [TBL] [Abstract][Full Text] [Related]
15. Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials. Meier MA; Branche A; Neeser OL; Wirz Y; Haubitz S; Bouadma L; Wolff M; Luyt CE; Chastre J; Tubach F; Christ-Crain M; Corti C; Jensen JS; Deliberato RO; Kristoffersen KB; Damas P; Nobre V; Oliveira CF; Shehabi Y; Stolz D; Tamm M; Mueller B; Schuetz P Clin Infect Dis; 2019 Jul; 69(3):388-396. PubMed ID: 30358811 [TBL] [Abstract][Full Text] [Related]
16. Procalcitonin-guided antibiotic therapy may shorten length of treatment and may improve survival-a systematic review and meta-analysis. Papp M; Kiss N; Baka M; Trásy D; Zubek L; Fehérvári P; Harnos A; Turan C; Hegyi P; Molnár Z Crit Care; 2023 Oct; 27(1):394. PubMed ID: 37833778 [TBL] [Abstract][Full Text] [Related]
17. Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross-over, interventional study. Chomba RN; Moeng MS; Lowman W S Afr J Surg; 2020 Sep; 5(3):143-149. PubMed ID: 33231007 [TBL] [Abstract][Full Text] [Related]